S
SIGA Technologies, Inc. (SIGA)
NGM – Real Time Price. Currency in USD
5.30
+0.34 (6.85%)
At close: Mar 27, 2026, 4:00 PM EDT
5.24
-0.06 (-1.13%)
After-hours: Mar 27, 2026, 7:01 PM EDT
Get all premium features to the best stock analysis tool
NGM – Real Time Price. Currency in USD
5.30
+0.34 (6.85%)
At close: Mar 27, 2026, 4:00 PM EDT
5.24
-0.06 (-1.13%)
After-hours: Mar 27, 2026, 7:01 PM EDT
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company’s lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
| Name | Position |
|---|---|
| Dr. Dennis E. Hruby Ph.D. | Executive VP & Chief Scientific Officer |
| Dr. Diem Nguyen M.B.A., Ph.D. | CEO & Director |
| Mr. Daniel J. Luckshire CPA, M.B.A. | Executive VP, CFO & Secretary |
| Mr. Herb Vloedman | Senior VP & Chief Information Officer |
| Mr. Lawrence R. Miller Esq., J.D. | General Counsel & Corporate Secretary |
| Date | Type | Document |
|---|---|---|
| 2026-03-10 | 10-K | siga20251231_10k.htm |
| 2025-11-06 | 8-K | ef20058429_8k.htm |
| 2025-08-05 | 10-Q | siga20250630_10q.htm |
| 2025-06-12 | 8-K | ef20050546_8k.htm |
| 2025-05-08 | 10-Q | siga20250331_10q.htm |
| 2025-04-28 | DEF 14A | ny20044196x2_def14a.htm |
| 2025-04-18 | PRE 14A | ny20044196x1_pre14a.htm |
| 2025-04-08 | 8-K | ef20047038_8k.htm |
| 2025-03-18 | 8-K | ef20045652_8k.htm |
| 2025-03-11 | 10-K | siga20241231_10k.htm |